Adicet bio added to the russell 2000® index

Menlo park, calif. and boston, june 28, 2021 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer and other diseases, today announced that the company has been added to the russell 2000® index, effective june 28, 2021, as part of the 2021 russell indexes annual reconstitution.
ACET Ratings Summary
ACET Quant Ranking